Hekat is developing an innovative biomedical instrument to sort biological nano objects (e.g. exosomes) by functional biomarkers. Exosomes are extracellular vesicles released by cells. They carry physio-pathological information particularly relevant in the case of cancers. Thanks to our revolutionary technology we can deliver pure sub-populations, concentrated enough for immediate analysis (PCR or proteomics), enabling the development of completely new, precise and diagnoses for oncology.

CEO : Sophie BOURZEIX

Contact : sophie.bourzeix@hekat.com

Website: https://hekat.com/